Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06287762 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Natural History Study of RYR1-Related Disorders

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 212 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Minor Eligibility criteria expanded, about 20 words
    • Study description expanded, about 73 words
    • Site contact updated
  2. Minor 3 versions Re-verified since Dec 3, 2025, no change to tracked fieldsv209-v211
  3. Minor Eligibility criteria revisedv208
  4. Minor Study description expanded, about 245 wordsv207
  5. Minor Re-verified, no change to tracked fieldsv206
Show 43 earlier versionsHide 43 earlier versions
  1. Minor Start date changed from estimate of Mar 18, 2025 to Mar 11, 2025v205
  2. Minor Start date: Mar 17, 2025 to Mar 18, 2025v204
  3. Minor Start date: Mar 16, 2025 to Mar 17, 2025v203
  4. Minor Start date: Mar 13, 2025 to Mar 16, 2025v202
  5. Minor Start date: Mar 12, 2025 to Mar 13, 2025v201
  6. Minor Start date: Mar 11, 2025 to Mar 12, 2025v200
  7. Minor Start date: Mar 10, 2025 to Mar 11, 2025v199
  8. Minor Start date: Mar 9, 2025 to Mar 10, 2025v198
  9. Minor Start date: Mar 6, 2025 to Mar 9, 2025v197
  10. Minor Start date: Mar 5, 2025 to Mar 6, 2025v196
  11. Minor Start date: Mar 4, 2025 to Mar 5, 2025v195
  12. Notable Lead sponsor: National Institute of Nursing Research (NINR) to National Institutes of Health Clinical Center (CC)
    • Start date: Mar 3, 2025 to Mar 4, 2025
    v194
  13. Minor Start date: Mar 2, 2025 to Mar 3, 2025v193
  14. Minor Start date: Feb 27, 2025 to Mar 2, 2025v192
  15. Minor Start date: Feb 26, 2025 to Feb 27, 2025v191
  16. Minor Start date: Feb 25, 2025 to Feb 26, 2025v190
  17. Minor Start date: Feb 24, 2025 to Feb 25, 2025v189
  18. Minor Start date: Feb 23, 2025 to Feb 24, 2025v188
  19. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date: Feb 20, 2025 to Feb 23, 2025
    • Site details revised
    v187
  20. Minor Start date: Feb 19, 2025 to Feb 20, 2025v186
  21. Minor Start date: Feb 18, 2025 to Feb 19, 2025v185
  22. Minor Start date: Feb 17, 2025 to Feb 18, 2025v184
  23. Minor Start date: Feb 16, 2025 to Feb 17, 2025v183
  24. Minor Start date: Feb 13, 2025 to Feb 16, 2025
    • Study description expanded, about 6 words
    v182
  25. Minor Start date: Feb 12, 2025 to Feb 13, 2025v181
  26. Minor Start date: Feb 11, 2025 to Feb 12, 2025v180
  27. Minor Start date: Feb 10, 2025 to Feb 11, 2025v179
  28. Minor Start date: Feb 9, 2025 to Feb 10, 2025v178
  29. Minor Start date: Feb 6, 2025 to Feb 9, 2025v177
  30. Minor Start date: Feb 5, 2025 to Feb 6, 2025v176
  31. Minor Start date: Feb 4, 2025 to Feb 5, 2025v175
  32. Minor Start date: Feb 3, 2025 to Feb 4, 2025v174
  33. Minor Start date: Feb 2, 2025 to Feb 3, 2025v173
  34. Minor Start date: Jan 30, 2025 to Feb 2, 2025v172
  35. Minor Start date: Jan 29, 2025 to Jan 30, 2025v171
  36. Minor Start date: Jan 28, 2025 to Jan 29, 2025v170
  37. Minor Start date: Jan 27, 2025 to Jan 28, 2025v169
  38. Minor Start date: Jan 22, 2025 to Jan 27, 2025v168
  39. Minor Start date: Jan 21, 2025 to Jan 22, 2025v167
  40. Minor Start date: Jan 20, 2025 to Jan 21, 2025v166
  41. Minor Start date: Jan 19, 2025 to Jan 20, 2025v165
  42. Minor Start date: Jan 16, 2025 to Jan 19, 2025v164
  43. Minor Start date: Jan 15, 2025 to Jan 16, 2025v163
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: Congenital myopathies (CM) are genetic disorders that can cause decreased muscle tone and muscle weakness. Most CMs in the United States are related to the ryanodine receptor 1 (RYR1) gene. Researchers need more natural history data to learn about these CMs in children and adults. Objective: To learn more about the signs, symptoms, and course of RYR1-related disorders. Eligibility: People aged 7 years and older with an RYR1-related disorder. Design: Ambulatory participants will come to the Clinical Center and non-ambulatory participants will visit via telehealth. Visits will be once a year for 3 or 5 years. Clinical Center visits will take 2 to 3 days. All participants will undergo tests including: Photos and videos. These will be taken to document the participant s condition. Blood and urine tests. Activity Tracker. Participants will wear a device to record their activity. Questionnaires. Participants will answer questions about their health, pain, fatigue, stress, quality of life, and other topics. Participants who visit the Clinical Center will also undergo: Tests of heart and lung function. Motor skills and strength tests. Participants will walk, climb stairs, kneel, crawl, stand up, and perform other movements to test their strength and abilities. They will squeeze and pinch a handheld device to test their grip. Imaging scans. Skin biopsy. Adult participants may opt to have a sample of skin taken (one time only). Eye exam
Trial Details
NCT Number NCT06287762
Lead Sponsor National Institutes of Health Clinical Center (CC)
Conditions
(from sponsor)
Ryanodine Receptor 1-Related Myopathy, Ryanodine Receptor 1 Related Disorders
Related terms Muscular Diseases, Myotonia Congenita
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov